Bright Minds Biosciences Inc. (DRUG)
DRUG Stock Price Chart
Explore Bright Minds Biosciences Inc. interactive price chart. Choose custom timeframes to analyze DRUG price movements and trends.
DRUG Company Profile
Discover essential business fundamentals and corporate details for Bright Minds Biosciences Inc. (DRUG) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
22 Mar 2021
Employees
—
Website
https://brightmindsbio.comCEO
Ian McDonald
Description
Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.
DRUG Financial Timeline
Browse a chronological timeline of Bright Minds Biosciences Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 29 Dec 2025
EPS estimate is -$0.71.
Earnings released on 14 Aug 2025
EPS came in at -$0.53 surpassing the estimated -$0.59 by +10.17%.
Earnings released on 15 May 2025
EPS came in at -$0.29 surpassing the estimated -$0.39 by +25.64%.
Earnings released on 13 Feb 2025
EPS came in at $0.01 surpassing the estimated -$0.23 by +104.35%.
Earnings released on 30 Dec 2024
EPS came in at -$0.12 surpassing the estimated -$0.44 by +72.94%.
Earnings released on 14 Aug 2024
EPS came in at $0.04 .
Earnings released on 15 May 2024
EPS came in at -$0.10 .
Earnings released on 12 Feb 2024
EPS came in at -$0.32 .
Earnings released on 29 Dec 2023
EPS came in at -$0.30 .
Earnings released on 14 Aug 2023
EPS came in at -$0.29 .
Stock split effective on 14 Jul 2023
Shares were split 1 : 5 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 15 May 2023
EPS came in at -$0.08 .
Earnings released on 7 Feb 2023
EPS came in at -$0.10 .
Earnings released on 29 Dec 2022
EPS came in at -$0.15 .
Earnings released on 12 Aug 2022
EPS came in at -$0.87 .
Earnings released on 16 May 2022
EPS came in at -$1.51 .
Earnings released on 14 Feb 2022
EPS came in at -$1.61 .
Earnings released on 29 Dec 2021
EPS came in at -$0.24 .
Earnings released on 17 Jul 2021
EPS came in at -$1.26 .
Earnings released on 17 Jun 2021
EPS came in at -$0.46 .
Earnings released on 31 Mar 2021
EPS came in at -$0.91 .
Earnings released on 30 Sept 2020
EPS came in at -$0.25 .
DRUG Stock Performance
Access detailed DRUG performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.